Bioethics News

Gene-Edited Cells Keep Cancer Babies Well More Than One Year On

January 25, 2017

(Reuters) – Two babies rescued from previously incurable leukemia after receiving infusions of gene-edited immune cells are doing well at home more than a year after initial treatment, scientists said on Wednesday. Layla Richards became the first person in the world to get the “off-the-shelf” cell therapy developed by French biotech firm Cellectis at Britain’s Great Ormond Street Hospital in 2015. A second girl was treated soon afterwards. Now the team involved in both cases have published details of their work in a peer-reviewed journal, reporting that the two girls remained disease-free 18 and 12 months after treatment respectively.

The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.